Podcasts about clinical science

In a recent episode of Oncology on the Go, several oncologists discussed the impact of the COVID-19 pandemic on oncology care, 5 years later. Each doctor discussed a different aspect of multidisciplinary care, including medical oncology, radiation oncology, and epidemiology. CancerNetwork® spoke with leading clinicians including:  ·      Aditya Bardia, MD, MPH, FSCO, professor in the Department of Medicine, Division of Hematology/Oncology, and director of Translational Research Integration at the University of California Los Angeles Health Jonsson Comprehensive Cancer Center; ·      Ritu Salani, MD, director of Gynecologic Oncology at the University of California Los Angeles, and ONCOLOGY® editorial advisory board member; ·      Scarlett Lin Gomez, PhD, MPH, a professor in the Department of Epidemiology and Biostatistics at the University of California San Francisco (UCSF), and co-leader of the Cancer Control Program at UCSF Helen Diller Family Comprehensive Cancer Center ·      Marwan F. Fakih, MD, professor in the Department of Medical Oncology & Therapeutics Research, associate director for Clinical Sciences, medical director of the Briskin Center for Clinical Research, division chief of GI Medical Oncology, and co-director of the Gastrointestinal Cancer Program at City of Hope Comprehensive Cancer Center; ·      Elizabeth Zhang-Velten, MD, a radiation oncologist at Keck Medicine of University of Southern California;  ·      Frances Elain Chow, MD, neuro-oncologist at the University of Southern California (USC) Norris Comprehensive Cancer Center ·      James Yu, MD, MHS, FASTRO, assistant professor adjunct, Department of Radiation Oncology, Smilow Cancer Hospital at Saint Francis Hospital, and ONCOLOGY® editorial advisory board member.  The COVID-19 pandemic disrupted routine cancer care in a number of ways. Many patients were unable to receive timely screening, diagnosis, and treatment, Fakih noted. Additionally, Bardia stated that the pandemic led to a decrease in the number of patients participating in clinical trials. One of the most significant changes in oncology care, according to Salani, has been the increased use of telehealth. Telehealth has allowed patients to receive care from the comfort of their own homes, which has been especially beneficial for patients who live in rural areas or who have difficulty traveling. Telehealth has also made it easier for patients to connect with their doctors and to receive support from other members of their care team.  For Gomez, the COVID-19 pandemic also highlighted the importance of addressing the structural and social drivers of health. These are the conditions in which people are born, grow, live, work, and age that can affect their health. For example, people who live in poverty or who lack access to healthy food are more likely to develop cancer. The pandemic has led to a renewed focus on addressing these disparities. Overall, the COVID-19 pandemic has had a profound impact on oncology care. However, it has also led to a number of positive changes, such as the increased use of telehealth and the focus on addressing the structural and social drivers of health. In the years to come, it will be important to continue to build on these changes in order to improve the lives of patients with cancer.

In a conversation with CancerNetwork®, Marwan G. Fakih, MD, spoke about the FDA approval of sotorasib (Lumakras) plus panitumumab (Vectibix), and how it may affect the treatment paradigm for patients with KRAS G12C-mutant metastatic colorectal cancer (CRC). Fakih is a professor in the Department of Medical Oncology & Therapeutics Research, associate director for Clinical Sciences, medical director of the Briskin Center for Clinical Research, division chief of GI Medical Oncology, and co-director of the Gastrointestinal Cancer Program at City of Hope Comprehensive Cancer Center in Duarte, California. According to Fakih, the approval of this combination regimen is a “welcome step” for those with metastatic CRC harboring KRAS G12C mutations. Based on supporting data from the phase 3 CodeBreaK 300 trial (NCT05198934), sotorasib/panitumumab may prolong progression-free survival (PFS) and reduce disease burden in patients while offering improvements in other outcomes vs prior standards of care (SOC) like trifluridine/tipiracil (Lonsurf) and regorafenib (Stivarga). Topline data at the time of the approval showed a median PFS of 5.6 months (95% CI, 4.2-6.3) with sotorasib at 960 mg plus panitumumab vs 2.0 months (95% CI, 1.9-3.9) in the SOC arm, in which patients were assigned to receive trifluridine/tipiracil or regorafenib (HR, 0.48; 95% CI, 0.30-0.78; P = .005). Additionally, the overall response rate was 26% (95% CI, 15%-40%) vs 0% (95% CI, 0%-7%) in each respective arm. Looking ahead, Fakih highlighted the potential next steps for research associated with the sotorasib combination as well as other novel therapeutic strategies in the gastrointestinal cancer space. For example, he described the phase 3 CodeBreaK 301 study (NCT06252649), which will evaluate sotorasib/panitumumab as frontline therapy when administered in combination with folinic acid, fluorouracil, and irinotecan (FOLFIRI) vs FOLFIRI plus bevacizumab (Avastin) in metastatic KRAS G12C-mutant CRC. Other novel agents under development in the space include RAS inhibitors and immunotherapy regimens combining CTLA-4 inhibitors with anti–PD-L1 agents. References 1. FDA approves sotorasib with panitumumab for KRAS G12C-mutated colorectal cancer. News release. FDA. January 16, 2025. Accessed February 12, 2025. https://shorturl.at/1WviB 2. Kim TW, Price T, Grasselli J, et al. A phase 3 study of first-line sotorasib, panitumumab, and FOLFIRI versus FOLFIRI with or without bevacizumab-awwb for patients with KRAS G12C–mutated metastatic colorectal cancer (CodeBreaK 301). J Clin Oncol. 2025;43(suppl 4):TPS326. doi:10.1200/JCO.2025.43.4_suppl.TPS326

LATE BREAKING CLINICAL SCIENCE: Benefits of Dynamx Bioadaptor Versus DES in Patients With Dyslipidemia: Subgroup Analysis Results from the BIOADAPTOR RCT

Dr. David Brady is the Chief Medical Officer for Designs for Health, Inc. and Diagnostic Solutions Labs, LLC and an expert consultant for nutritional supplements and clinical laboratory industries. He has over 30 years of experience as an integrative practitioner and more than 25 years in health sciences academia. He is a licensed naturopathic medical physician in Connecticut and Vermont; he is board certified in functional medicine and clinical nutrition; and he is a Fellow of the American College of Nutrition. He held the long-time position as Vice President for Health Sciences and Director of the Human Nutrition Institute at the University of Bridgeport in Connecticut, where he continues to serve as an Associate Professor of Clinical Sciences, and he maintains a private practice, Whole Body Medicine, in Fairfield, CT, USA. Dr. Brady has returned to the podcast for a discussion about fibromyalgia and offers a variety of clinical pearls throughout our conversation. He highlights the differentiating features between fibro and pseudo-fibromyalgia, explains the evolution of our understanding of fibro diagnostic markers and subsequent treatments, and details the environmental triggers, predisposition and trauma that tend to lead to the onset of fibromyalgia. He also offers potential solutions that utilize supplements for mitochondrial support and deficiencies and offers an update on long COVID and increased autoimmunity in the population at large. I'm your host, Evelyne Lambrecht, thank you for designing a well world with us.   Episode Resources: Dr. David Brady - https://dss.designsforhealth.com/blogs/faculty-member/david-m-brady Design for Health Resources: Designs for Health - https://www.designsforhealth.com/ Designs for Health Practitioner Exclusive Drug Nutrient Depletion and Interaction Checker - https://www.designsforhealth.com/drug-nutrient-interaction/ Visit the Designs for Health Research and Education Library which houses medical journals, protocols, webinars, and our blog. https://www.designsforhealth.com/research-and-education/education The Designs for Health Podcast is produced in partnership with Podfly Productions. Chapters: 00:00 Intro. 01:50 Dr. Brady is looking forward to the future of Designs for Health. 3:00 A definition of fibromyalgia and the parts of the body that are widely affected by it. 7:33 Differentiating features between fibro and pseudo-fibromyalgia. 9:32 The evolution of our understanding of fibro diagnostic markers and subsequent treatments. 15:25 Common nervous system set up that leads to fibromyalgia later in life. 18:25 Findings and actions resulting from cytokine testing, heightened neural inflammation, and glial cell activation. 23:00 Updates on the link between fibromyalgia and long-haul COVID 19. 26:14 The use of 5-HTP in regulating limbic system dysfunction, neurotransmitters and heightened pain receptors. 31:55 Utilizing botanicals in calming adaptogens and those that are not stimulating. 33:05 5-HTP use for those with SNPs in MAO-A or -B for brain retraining in calming and relaxation. 36:36 Fibromyalgia pain is presented in constant and regular symptomatology. 38:45 Environmental triggers that bring on fibromyalgia, in addition to the intersection of predisposition and trauma. 44:06 Gender and hormonal differences in the onset and presentation of fibromyalgia. 45:50 Potential solutions that utilize supplements for mitochondrial support and deficiencies.  51:56 Managing inflammatory and joint pain in fibromyalgia. 54:42 Dietary patterns and food sensitivities that are common in patients with fibromyalgia. 56:48 Peptide therapy options for patients with fibromyalgia. 59:29 An update on long Covid and increased autoimmunity in the population at large. 1:02:48 Dr. Brady's latest intrigue supplements, current health practices, and the need to be right all of the time that he has changed his mind about.

LATE BREAKING CLINICAL SCIENCE: AltaValve Atrial Fixation TMVR Early Feasibility Study Results

Praveen Kumar, Director and Heard of Clinical Sciences at nference, a physician, clinical pharmacologist and an advocate for real-world data in drug development and medical devices. Praveen is passionate about leveraging AI, machine learning and data-driven insights to optimize clinical trials, reduce development costs and improve patient outcomes In this episode, we explore the critical role of real-world data in shaping the future of medicine, how it differs from traditional clinical trials and why it's increasingly being used for regulatory approvals. Praveen shares real-world case studies of drugs and devices that have successfully used real-world data, the challenges in global regulatory acceptance and how AI is transforming patient recruitment and trial efficiency Timestamps: [00:00:27] What is Real-World Data? [00:02:30] The Key Differences Between Clinical Trials and Real-World Data [00:06:46] How Real-World Data is Used for Drug Approvals [00:08:28] Cutting Drug Development Costs with AI [00:15:33] The Growing Role of Drug-Device Combinations [00:21:53] Emerging Trends in AI and Real-World Evidence [00:25:38] Challenges in Global Regulatory Acceptance Get in touch with Praveen Kumar - https://www.linkedin.com/in/praveen-kumar-m-33a6bab3/ https://nference.com/ Get in touch with Karandeep Badwal - https://www.linkedin.com/in/karandeepbadwal/ Follow Karandeep on YouTube - https://www.youtube.com/@KarandeepBadwal Subscribe to the Podcast

Dr. Leslie Ellis is a leading expert in the use of somatic approaches in psychotherapy, in particular for working with dreams, nightmares and the effects of trauma. She is the author of A Clinician's Guide to Dream Therapy (Routledge, 2019) and offers many training opportunities in embodied, experiential dreamwork based on her book.Dr. Ailey Jolie holds a Master of Counselling Psychology and a Master of Arts in Depth Psychology with an Emphasis in Somatic Studies, and is a graduate of Harvard Medical School's Global Mental Health: Trauma Recovery Masters certificate program. Ailey also possesses two Honours Bachelor Degrees in Women's Studies, Communication and Psychology from the University of Ottawa (Université d'Ottawa). She has completed postgraduate training in Sex Therapy from Guelph University, a certificate in Sex Therapy from the Modern Sex Therapy Institute (online), Perinatal Psychology from Postpartum Support International and training in the Clinical Science of Eating Disorders from the University College London Faculty of Medicine.In This EpisodeLeslie's websiteAiley's website---If you'd like to support The Trauma Therapist Podcast and the work I do you can do that here with a monthly donation of $5, $7, or $10: Donate to The Trauma Therapist Podcast.Click here to join my email list and receive podcast updates and other news.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-trauma-therapist--5739761/support.

In today's episode, supported by BeiGene, Alexey Danilov, MD, PhD, hosted a discussion with Susan M. O'Brien, MD, about key data updates with BTK inhibitors in patients with chronic lymphocytic leukemia (CLL) that were presented at the 2024 ASH Annual Meeting. Dr Danilov is the Marianne and Gerhard Pinkus Professor of Early Clinical Therapeutics, the medical director of the Early Phase Therapeutics Program for the Systems Clinical Trials Office, co-director of the Toni Stephenson Lymphoma Center, and a professor in the Division of Lymphoma at the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope in Duarte, California. Dr O'Brien is the associate director for Clinical Science at the Chao Family Comprehensive Cancer Center, the medical director of the Sue & Ralph Stern Center for Clinical Trials & Research, and a professor of medicine in the Division of Hematology/Oncology in the University of California Irvine School of Medicine. In our exclusive interview, Drs Danilov and O'Brien discussed potentially practice-changing data with acalabrutinib (Calquence)–based regimens from the phase 3 AMPLIFY trial (NCT03836261) in CLL, key updates with zanubrutinib (Brukinsa) as monotherapy and in combination with sonrotoclax (BGB-11417) in patients with this disease, and practice-confirming findings with pirtobrutinib (Jaypirca) from the phase 3 BRUIN CLL-321 trial (NCT04666038) in patients with previously treated CLL.

Everyone who has a foot in the world of psychiatric diagnosis seems to agree that our diagnostic system could, at the very least, use some updating, if not burning it down and starting over.So how do we approach developing constructs of psychiatric diagnoses that are more complex, more accurate, more flexible, and more context-specific than what we've been taught or what exists in the DSM-V?Today, I'm excited to share my conversation with Dr. Miri Forbes, an expert in psychopathology and one of the authors of the paper, “Reconstructing Psychopathology: A Data-Driven Reorganization of the Symptoms in the Diagnostic and Statistical Manual of Mental Disorders.” Dr. Forbes and her colleagues are doing innovative research on creating more empirically-supported diagnostic constructs. This approach to symptoms, categorization, and how we think about and use diagnostic constructs is one that I hope will help us get out of the habit of taking our current diagnostic constructs too literally.Dr. Forbes, an Associate Professor at Macquarie University's School of Psychological Sciences, is focused on improving our understanding of the empirical structure of psychopathology based on the specific patterns in which symptoms of mental disorders tend to co-occur.She is an Associate Editor of The Journal of Psychopathology and Clinical Science,and serves on the Editorial Boards of Clinical Psychological Science and The Journal of Emotion and Psychopathology. Additionally, Dr. Forbes is a member of the Executive Board of the international Hierarchical Taxonomy of Psychopathology (HiTOP) Consortium.Listen to the full episode to hear:How a dimensional model can potentially help decrease stigmatizing and pathologizing of individual human experiencesHow the regrouping of symptoms creates potential for more fruitful research into how and why symptoms cluster and how best to treat themWhy reliance on current categorization and diagnostic criteria can cause clinicians to miss or lose vital information about clientsReckoning with the utility of existing diagnoses like BPD that may lack statistical supportLearn more about Dr. Miri Forbes:WebsiteTwitter: @MiriForbesLearn more about Riva Stoudt:Into the Woods CounselingThe Kiln SchoolInstagram: @atherapistcantsaythatResources:Reconstructing Psychopathology: A data-driven reorganization of the symptoms in the Diagnostic and Statistical Manual of Mental Disorders

GUEST 1 OVERVIEW: Bernie Finn is Family First's Victorian Lead Senate Candidate. A political veteran, he was the most vocal conservative member in the Victorian Parliament since first taking office in 1992. Bernie was a beacon for traditional Liberal Party values which the current leadership had rejected. As a result of his strong stance on a number of issues, he was expelled from the parliamentary Liberal Party in 2022. https://berniefinn.com/ GUEST 2 OVERVIEW: Prof. Dominique Cadilhac is Co-director and Research Lead of the  Stroke and Ageing Group, School of Clinical Sciences at Monash University. 

In this episode we talk to Prof Katie Witkiewitz about non-abstinent recovery and the role of drinking reductions in reducing alcohol-related harm. We discuss this from both a public health perspective, and the role of abstinence or drinking reduction goals in the context of treatment and recovery. Professor Katie Witkiewitz is a Distinguished Professor of Psychology and the Director of the Center on Alcohol, Substance use, And Addictions at the University of New Mexico. Professor Witkiewitz is also a licensed clinical psychologist and has worked extensively on the development, evaluation, and implementation of mindfulness-based treatments for substance use disorder. She serves on the United States National Advisory Council on Alcohol Abuse and Alcoholism and on the Board of Scientific Counselors for the National Institute on Drug Abuse. Professor Witkiewitz is Editor of Psychology of Addictive Behaviors, and serves on the editorial boards of Substance Use and Misuse, Alcohol and Alcoholism, Annual Reviews: Clinical Psychology, and Journal of Psychopathology and Clinical Science. Her research has been supported by multiple grants from the National Institutes of Health, totaling over $90 million in research funding since 2004. She has authored 6 books and over 300 peer-reviewed publications, and has given over 100 presentations and invited talks. Support the Show.For more episodes visit https://alcoholpodcast.buzzsprout.com/Follow us at @alcoholpodcast on X and Instagram

Regular exercise is one of the most effective methods to keep the heart healthy and efficient. In rare cases, however, there are reports of athletes collapsing mid-game due to cardiac arrest. And while exercise is generally also a key part of the rehabilitation process for those who've experienced cardiac events, caution should still be taken. This is where physician input is important, and where testing and regular monitoring can be implemented to reduce the risk of further events. Today, we're joined by experts in the fields of sports cardiology and exercise physiology, as well as an athlete with firsthand experience in the matter, to draw attention to the topic of cardiac health and how it pertains to sports medicine. In this episode, host Myra Cocker, Assistant Professor of Cardiology at Houston Methodist Hospital and Global Director of Clinical Science for Cardiovascular Ultrasound at Siemens Healthineers, welcomes Dr. Jonathan Kim, Associate Professor and Founding Director at Emory University Sports Cardiology and Team Cardiologist for Georgia Tech, the Atlanta Falcons, Hawks, and Braves; as well as Dr. Dominique Hansen, Professor of Rehabilitation and Exercise Physiology in Cardiometabolic Diseases at Universiteit Hasselt in Belgium and Secretary of the European Association of Preventive Cardiology; and retired professional soccer player and cardiology patient Daniel Engelbrecht. What you'll learn in this episode:How cardiac risk can affect older and younger elite athletes differentlyCardiac events can stem from myocarditis, caused by an infectious disease.Red flag symptoms when it comes to cardiac events while exercising, including intense chest pressure or loss of consciousnessThe use of Automated External Defibrillators is a critical first response strategy in the event of cardiac arrest.Implementation of an exercise program can be essential when treating a patient who has experienced, or is at risk for, cardiovascular disease.For patients who have suffered from major cardiac events, their timeline for return to sports or intense physical activity is heavily dependent on a number of individual factors.Connect with Myra CockerLinkedInConnect with Jonathan KimLinkedInConnect with Dominique HansenLinkedInConnect with Daniel EngelbrechtLinkedIn Hosted on Acast. See acast.com/privacy for more information.

In this episode, I explore the role of phototherapy in treating psoriasis and how it compares to the more commonly discussed biologics. I'm joined by Dr. Joel Gelfand, the Director of the Center for Clinical Sciences in Dermatology and Psoriasis and Phototherapy Treatment Center at the University of Pennsylvania's Perelman School of Medicine. Dr. Gelfand has made significant contributions to our understanding of phototherapy's effectiveness for psoriasis patients. Together, we delve into the nuances of how phototherapy works, its benefits, and its place in modern dermatological care. Tune in to gain valuable insights from our conversation. Connect with me across Social: Instagram:https://www.instagram.com/drhannahkopelman/ TikTok: https://www.tiktok.com/@drhankopelman Twitter: https://twitter.com/drhankopelman Pinterest: https://www.pinterest.com/drhankopelman/ Personal Site: https://www.hannahkopelman.com The content of this podcast is for entertainment and educational purposes only. This content is not meant to be a substitute for medical advice or treatment for any medical condition. --- Send in a voice message: https://podcasters.spotify.com/pod/show/hannah-kopelman/message

Dr. Jason Schiffman is Professor of Clinical Science and the inaugural Director of Clinical Training for UCI's Clinical Psychology program. He received his Ph.D. in Clinical Psychology from the University of Southern California in 2003. Dr. Schiffman is founder and past Co-Director of the Maryland Early Intervention Program's Strive for Wellness Clinic. more: getthefunkoutshow.kuci.org

When did saying "I'm so stressed" become the norm? Stress seems to be a given for anyone out there adulting so it's hard to know when it becomes a problem and what to do about it. In this episode, we talk about stress with Dr. Matt Scult, VP of Clinical Science at Scenario, licensed psychologist, and Duke alum! We discuss what stress is, when is it helpful vs. harmful, and evidence-based tips to managing stress in healthy ways. He introduces Scenario, an app that helps people prepare for the stresses of everyday life. Resources:Check out Dr. Scult on Instagram @mattscultphd and his psychotherapy private practice​Check out Scenario that has a free basic version and a paid premium version coming soon! Support the Show. If you have a loved one struggling with mental health and need support, Dr. Kibby McMahon can help. Join the waitlist or email her at kibby@kulamind.com to learn more. For more info about this podcast, check out: www.alittlehelpforourfriends.com Follow us on Instagram: @ALittleHelpForOurFriends

The 19th Annual Spring Conference of the UK Center for Clinical and Translational Science (CCTS) drew it's largest-ever audience, with nearly 1,100 attendees including a particularly special guest: Lexington Mayor Linda Gorton, who issued a proclamation that April 9 is “Translational Science Day” in the city. Our own Dr. Greg Davis used the occasion to talk one-on-one with Philip Kern, M.D., co-director of the CCTS.

Michelle Holmes, OD, is a full-scope optometrist at the Pacific Neuroscience Institute®. She sees patients at both the Eye, Ear and Skull Base Center as well as at the Brain Health Center. She is board certified and TLG licensed to treat and manage ocular disease. She prides herself in practicing evidence-based medicine with a genuine enthusiasm for human connection.She earned her undergraduate degree in Molecular, Cellular, and Developmental biology from the University of Washington, Seattle. After her mother was diagnosed with a rare eye disease, she was inspired to pursue her Doctor of Optometry. She went on to complete her degree at the University of California, Berkeley. Her strong interest in ocular disease led her to successfully complete clinical externships at Omni Eye Services in the greater New York City area, the Southern Arizona VA Health Care System, and the Miami VA Hospital. She graduated with the distinction of Honors in Research and Clinical Science for her thesis on the efficacy of orthokeratology lenses for myopia control. This work was accepted for publication in Optometry and Vision Science (OVS), Journal of the American Academy of Optometry. Dr. Holmes is a current member of the American Optometric Association (AOA), the California Optometric Association (COA), and the Los Angeles County Optometric Association (LACOS).

Dr. Dan Cooper found his own path to health and healing through some of what he calls his “foundational experiences” or “dust-off experiences.” He now lives life in accordance with natural systems, which he believes is the truest path to idealized health. As a full-time faculty member at National University of Health Sciences, an avid researcher, an ocean rescue lifeguard, competitive athlete, and combat infantryman, he became obsessed with finding ways to maximize mental and physical performance for the sake of his own health and the safety of others. His life mission can be explained as: “Optimizing Genes Through Natural Means.” He resides in St. Petersburg, Florida with his wife and new baby, and two stellar pups and also maintains a part-time concierge chiropractic and functional medicine practice.   In this session we will discuss: 1.       How did an ATV accident, and brain bleed, inspire you to learn and then teach about the type of health you now practice? 2.       What is neurology functional medicine and how can it benefit the audience? 3.       What is “acro” (Acrobatic yoga), jams, and how do they help with focus? How does someone find a local community to learn and practice it? 4.       What do monkey sessions in the mangroves teach you about body movement and creating static and dynamic stability? 5.       As a full-time faculty member of the National University of Health Sciences, share with us about your passion for concussion health and pregnancy planning and idealizing the outcome of your fetus.  6.       What is the future of medicine and how does epigenetics and functional medicine play a role in that?   You can learn more about Dr. Dan Cooper by following him on Instagram at DrDanCooper

The question of how generative AI and other recent advances in technology will change medical education is one we're continually seeking answers to on Raise the Line, and today we're turning to a really well-placed expert to weigh in on this issue. He's Dr. Warren Wiechmann, senior associate dean of Clinical Science Education and Educational Technologies at University of California Irvine, a school known for its embrace of technology. Dr. Wiechmann is considered the architect of the school's iMedEd Initiative, a comprehensive curriculum that uses everything from augmented reality to 3D printing as catalysts for curricular innovation. As he tells host Michael Carrese, integration of technology across subjects has been a key element of UCI's approach. “We have our physiologists working closely with our anatomists, working closely with our clinical skills people. We're integrating point-of-care ultrasound into very early physiology lectures. We even have our physiologists doing a session using EKG devices.” Wiechmann stresses, though, that new tech has to meet a high bar for effectiveness before being used instructionally. “Just because it's new technology doesn't mean it's going to be useful.” As for the impact of generative AI, Wiechmann is keeping his eye on managing for inherent bias in large data sets and leveraging AI to help level the playing field for students with learning differences.  Tune in to learn more about this fascinating educational evolution. Mentioned in this episode: https://medschool.uci.edu/

GDP Script/ Top Stories for Feb 7th   Publish Date:  Feb 6th   From the Drake Realty Studio Welcome to the Gwinnett Daily Post Podcast. Today is Wednesday, February 7th and Happy 61st Birthday to country singer Garth Brooks. ***02.07.24 – BIRTHDAY – GARTH BROOKS*** I'm Bruce Jenkins and here are your top stories presented by Gwinnett Public Schools. High-Speed Tragedy: Trooper and Motorcyclist Involved in Fatal Crash at Over 140 MPH Research Suggests Link Between Dementia, Air Pollution, and Sedentary Lifestyle Revolutionary Weight Loss Drug Could Also Help Manage Blood Pressure in Overweight Individuals Plus, my conversation with Leah McGrath from Ingles Markets on sugar in cereals. All of this and more is coming up on the Gwinnett Daily Post podcast, and if you are looking for community news, we encourage you to listen daily and subscribe! Break 1: GCPS LIVE READ   ***GCPS READ*** Hey, Gwinnett County! Don't forget to mark your calendar for the GCPS Teacher Job Fair in just 3 days! Join us on February 10th at 8am at the Gas South Convention Center. This is a golden opportunity to be a part of Gwinnett County Public Schools - Georgia's largest school district and a top employer recognized by Forbes. Whether you're kick-starting your career or seeking a change, your passion for education could find its perfect home with us. Say 'yes' to GCPS, where passion meets opportunity! STORY 1: Fatal Crash Involving Trooper and Motorcyclist Exceeded Speeds of 140 MPH Gerson Danilo Ayala Rodriguez, a 21-year-old from Norcross, led a Georgia State Trooper on a high-speed chase exceeding 140 mph on his motorcycle on January 28, causing the trooper, Jimmy Cenescar, to lose control of his patrol car and crash, resulting in his death. Rodriguez, who lacked a driver's license and a valid license plate, has been arrested and charged with murder, vehicular homicide, and several other offenses. The Georgia Department of Public Safety worked diligently to investigate the incident. Trooper Cenescar, 28, was a recent graduate of Georgia Gwinnett College and had joined the department in January 2023. Visitation and funeral services for Cenescar will be held later this week. STORY 2: Laziness and air pollution largely to blame for dementia: study A new study suggests that dementia, including Alzheimer's disease, was extremely rare in ancient times, with modern lifestyles and environments largely to blame for its prevalence today. Analysis of ancient Greek and Roman texts reveals few mentions of cognitive decline comparable to Alzheimer's. As Roman cities grew denser, pollution increased, possibly driving up cases of cognitive decline. Additionally, Roman aristocrats' use of lead in cooking vessels and water pipes may have contributed to neurotoxicity. Modern-day Tsimane Amerindians, living a physically active lifestyle, have extremely low rates of dementia, highlighting the influence of modern environments on the condition. These findings suggest that lifestyle factors, such as sedentary behavior and pollution exposure, play a significant role in the rise of Alzheimer's disease.   STORY 3: New weight loss medication could lower blood pressure in obese adults A new weight loss medication, tirzepatide, has shown promise in lowering blood pressure in obese adults, according to a study published in the American Heart Association journal Hypertension. The medication significantly reduced systolic blood pressure, a strong predictor of cardiovascular death, in nearly 500 severely overweight adults. Tirzepatide works by mimicking metabolic hormones that regulate insulin secretion and sensitivity, leading to weight loss by reducing appetite and slowing down digestion. Participants taking tirzepatide experienced average reductions in systolic blood pressure of 7.4 mm Hg to 10.6 mm Hg, alongside significant weight loss. Lead author Professor James A. de Lemos noted the potential of tirzepatide in preventing or treating high blood pressure, but emphasized the need for further research to confirm these findings and understand long-term effects on cardiovascular health.   We have opportunities for sponsors to get great engagement on these shows. Call 770.874.3200 for more info. We'll be right back Break 2: TOM WAGES   STORY 4: Possible new treatment for rare disorder that causes babies to have extra fingers and toes Researchers at the University of Leeds may have discovered a treatment for a rare disorder causing extra fingers and toes, along with other birth defects, autism, and a large head circumference. The disorder currently has no treatment, but the research identified a molecule that could potentially treat neurological symptoms and prevent further deterioration. The drug is already in clinical trials for another disorder, expediting the process if found effective. Dr. James Poulter emphasized the importance of such research for patients and families facing years of uncertainty. The disorder stems from a genetic mutation in the MAX gene, identified through a study published in the American Journal of Human Genetics. Further research will explore the treatment's effectiveness and its potential to improve symptoms caused by the mutation. STORY 5: Adversity early in life can cause kid's brains to develop too fast A new study suggests that children exposed to early life adversity (ELA) undergo accelerated brain development during preschool years, potentially leading to negative health outcomes later in life. Researchers from A*STAR's Singapore Institute for Clinical Sciences studied 549 children, tracking brain development via MRI scans at ages 4.5, 6, and 7.5 years. They found that ELA is linked to accelerated brain development between ages 4.5 and 6, likely a protective response. However, this can shorten the window for adaptive learning and neuroplasticity, with implications for cognitive and mental health. Dr. Tan Ai Peng emphasized the importance of early intervention during this critical period to mitigate adverse effects. The study was published in the journal Nature Mental Health.   Break 3:  INGLES 5   STORY 6: LEAH MCGRATH And now here is my conversation with Leah McGrath from Ingles Markets on sugar in cereals.   STORY 7: LEAH MCGRATH ***LEAH MCGRATH INERVIEW***   We'll have final thoughts after this.   Break 4:   Signoff – Thanks again for hanging out with us on today's Gwinnett Daily Post podcast. If you enjoy these shows, we encourage you to check out our other offerings, like the Cherokee Tribune Ledger Podcast, the Marietta Daily Journal, the Community Podcast for Rockdale Newton and Morgan Counties, or the Paulding County News Podcast. Read more about all our stories and get other great content at Gwinnettdailypost.com. Did you know over 50% of Americans listen to podcasts weekly? Giving you important news about our community and telling great stories are what we do. Make sure you join us for our next episode and be sure to share this podcast on social media with your friends and family. Add us to your Alexa Flash Briefing or your Google Home Briefing and be sure to like, follow, and subscribe wherever you get your podcasts. Produced by the BG Podcast Network   Show Sponsors: ingles-markets.com wagesfuneralhome.com gcpsk12.org/jobs   #NewsPodcast #CurrentEvents #TopHeadlines #BreakingNews #PodcastDiscussion #PodcastNews #InDepthAnalysis #NewsAnalysis #PodcastTrending #WorldNews #LocalNews #GlobalNews #PodcastInsights #NewsBrief #PodcastUpdate #NewsRoundup #WeeklyNews #DailyNews #PodcastInterviews #HotTopics #PodcastOpinions #InvestigativeJournalism #BehindTheHeadlines #PodcastMedia #NewsStories #PodcastReports #JournalismMatters #PodcastPerspectives #NewsCommentary #PodcastListeners #NewsPodcastCommunity #NewsSource #PodcastCuration #WorldAffairs #PodcastUpdates #AudioNews #PodcastJournalism #EmergingStories #NewsFlash #PodcastConversationsSee omnystudio.com/listener for privacy information.

In this episode, we speak with Jasmina Cheeseman, PA-C, assistant professor of physician assistant studies at Franklin College in Franklin, IN. We discuss her transition from clinical laboratory science to the PA profession, advocacy, her journey into PA education, how applicants should prepare to stand out as a strong candidate, and what makes her program unique.    This episode is sponsored by Butler University Doctor of Medical Science Programs. 

If your child is afraid to speak around certain people, like adults or strangers, or in certain situations, like at school, they may be struggling with selective mutism. Selective mutism is an anxiety disorder characterized by an inability to speak in certain settings and to certain people. It is commonly misunderstood as shyness or a child could even be misdiagnosed as having Autism Spectrum Disorder or Oppositional Defiance Disorder. But what exactly is selective mutism and how can we tell the difference?  Today's guest helps demystify selective mutism and offers a lot of insight into ways we can help children thrive. Dr. Danielle Cornacchio is the newest member of ChildNEXUS! She is a clinical child psychologist specializing in evidence-based treatments for childhood anxiety, OCD, and disruptive behavior disorders. Dr. Cornacchio has particular expertise in behavioral treatment for childhood selective mutism. In this episode, Dr. Cornacchio explains what selective mutism is, but perhaps more importantly, she explains what it is not. She takes the time to describe what treatment for selective mutism might look like and emphasizes the importance of parent education and participation. Listen to learn more about this often misunderstood condition.   Show Notes: [2:27] - Selective mutism is classified as an anxiety disorder. It is a consistent failure to speak in certain situations despite speaking fine in others. [4:03] - Selective mutism is not Autism Spectrum Disorder or Oppositional Defiance Disorder. It is often misunderstood or misdiagnosed. [7:13] - Kids with selective mutism will typically speak around their parents and siblings at home but won't speak at school. [11:24] - Information and research on treatment for selective mutism is very new but Cognitive Behavioral Therapy is the most beneficial. [14:04] - Dr. Cornacchio shares some of the ways selective mutism shows up including learning situations where talking is not necessary and something called contamination. [17:58] - Therapy sessions once a week are not enough if parents and family members are not also working with a child at home. [21:14] - It's human nature to want to protect your children and reduce their stress, but to overcome challenges, children need to step out of their comfort zones. [24:13] - Dr. Cornacchio demonstrates the steps in early therapy sessions with children with selective mutism including behavior descriptions and labeled praise. [26:34] - The type of question that we ask a child who is ready to speak really matters. [28:11] - Giving children ample time to answer a question can be uncomfortable for parents. [29:29] - After 5 seconds of wait time, if the child does not answer, Dr. Cornacchio demonstrates how to rephrase the question and try something different. [31:47] - But what happens if the child still does not answer a question after different strategies? [33:29] - Teachers do not have the luxury of trying questions multiple times and waiting for answers. But there is a Plan B for teachers to not ever give up on a question. [37:37] - It is important to connect with a provider, but it is challenging to find one that treats selective mutism.   About Our Guest: Dr. Cornacchio completed her PhD in Clinical Science in Child and Adolescent Psychology at Florida International University and her predoctoral internship training at the UCLA Semel Institute. She currently serves as a clinical instructor at the UCLA Psychology Department. Dr. Cornacchio founded and currently directs The WaveMind Clinic in Los Angeles, a clinic dedicated to providing specialized care to children and families with a variety of mental health needs, including selective mutism, OCD, and disruptive behavior disorders. She directs a training program for psychology students and postdoctoral trainees learning Parent Child Interaction Therapy (PCIT) and treatment for childhood selective mutism. Dr. Cornacchio leads training for educators and professionals interested in learning more about how to treat selective mutism. Dr. Cornacchio's research interests focus on innovative treatment formats for difficult-to-treat child anxiety. She conducted the first randomized controlled trial of an intensive group treatment program for children with selective mutism and is currently co-authoring a manual that's in press on the delivery of intensive treatment for children with selective mutism.    Connect with Dr. Danielle Cornacchio: WaveMind Clinic Website ChildNEXUS Provider Profile Email: dcornacchio@wavemindclinic.com    Links and Related Resources: Selective Mutism Association website with many resources and a provider database Dr. Steve Kurtz's Selective Mutism Learning University self-guided course   Connect with Us: Get on our Email List Book a Consultation Get Support and Connect with a ChildNEXUS Provider Register for Our Self-Paced Mini Courses with LIVE AMA Sessions   The Diverse Thinking Different Learning podcast is intended for informational purposes only and is not a substitute for medical or legal advice, diagnosis, or treatment. Additionally, the views and opinions expressed by the host and guests are not considered treatment and do not necessarily reflect those of ChildNEXUS, Inc or the host, Dr. Karen Wilson.

In this Inside Health Care interview, we explore GME — graduate medical education — and explore a few fundamental questions. How can we make sure today's medical residents are paying attention to their patients? How do we teach residents to ask the right questions? And even more fundamentally, how do we make sure that the next generation of clinicians knows how to implement value-based models of care in order to focus on person-centered outcomes?A value-based model helps patients envision what their lives could be a few months, or even years, down the line. And that's the point at which clinicians can help patients develop a treatment plan to get them from point A to point B. That may be the best way to keep a patient healthy, boost their interest in their self-care and prevent repeat visits for the same problem.So the questions stand regarding graduate medical education. How do you teach med school students the value of quality? How do you train them to follow a model of value-based care? And if your hospital's HEDIS scores are low, how much of that is because of the residents? What's the correlation between medical residencies and health care quality?Michael Kanter, MD, is a professor and chair of Clinical Science at the Kaiser Permanente Bernard J. Tyson School of Medicine in Pasadena, California. In his work within Kaiser Permanente's health care system, he's overseen the quality of care provided by 22,000 physicians to 12.2 million patients. He also was responsible for development of Kaiser's national quality strategy. An expert in patient safety and clinical quality, he developed policy-based and software-based programs that decreased the number of missed or delayed diagnoses and increased patient engagement.Jung Kim, PhD, MPH, is Assistant Professor for Health Systems Science at the Kaiser Permanente Tyson School of Medicine, and a protégé of Dr. Kanter. Dr. Kim explores approaches to health care and healing, including studies on the roles of acupuncture and other East Asian practices as complementary or alternative medical treatments for cancer, H-I-V and other conditions. As we'll hear in our interview, Dr. Kim also investigates innovations in medical education residency programs, including analysis of email communication among medical students and new learning strategies for medical education.

 In this episode our guest, Nicole Woods, PhD joins Kate Mulligan, PhD to discuss how we can re-think the integration of basic and clinical sciences in medical education.  Collaborative Advocacy & Partnered Education (CAPE)The Wilson CentreCLIME Grand Rounds

Collaboration and connection are aspects we often emphasize in rural health. The rural advantage allows us to collaborate with each other and uniquely connect with our communities.  Our guest this week on Rural Health Leadership Radio is no stranger to collaboration. We are delighted to share with you our conversation with Kevin Bennett, a Professor at the University of South Carolina School of Medicine, Chair of the Department of Translational and Clinical Sciences, Director of the South Carolina Center for Rural & Primary Healthcare, and the Research Center for Transforming Health.  Dr. Bennett discusses his work in rural health, emphasizing the importance of addressing food insecurity and bridging gaps in healthcare access. He highlights the need for comprehensive solutions, including collaborations with medical education institutions. We also explore how to attract young professionals to a rural lifestyle. “Rural is more than a label, there's a beauty to it and a strength in the community connection.” -Kevin Bennett Dr. Bennett is Professor and Chair in the Department of Translational and Clinical Science, at the University of South Carolina School of Medicine, in Columbia, SC. He serves as the Director of the Research Center for Transforming Health and Director of the South Carolina Center for Rural and Primary Healthcare. He also serves on the National Rural Health Association's Board of Trustees and as President-Elect (2024).  His work focuses on care delivery for vulnerable and underserved populations and how policies and legislation affect these populations.  He has also worked extensively with community organizations, rural health networks, healthcare systems, and state agencies to create, facilitate, and evaluate the impact of innovative care delivery programs.

People in the horse racing, farming, and ranching industries have two things in common; a passion and love for animals.  Today's guest is a renowned equine orthopedic surgeon, a University Distinguished Professor in the Department of Clinical Sciences, and the founder of the Orthopaedic Research Center at CSU. It is clear when you hear him … Read More Read More

On this episode are joined by Alyssa Phillips, an occupational therapist who has spent a large majority of her clinical practice and research on how patients perceive pain and the relationship between psychological factors and pain. On this episode, she shares with us the importance of recognizing how psychological factors can have an effect on our patient's recovery. She also shares strategies for maximizing our patient's functional outcomes while addressing their pain. Guest bio:Alyssa L. Phillips, CScD, MOT, OTR/LAlyssa graduated from Saint Francis University with her Masters of Occupational therapy and later with her Doctorate in Clinical Science from the University of Pittsburgh, focusing on adolescent pain management. Alyssa brings a unique background with an undergraduate degree in psychology to her practice as an occupational therapist. For the last six years, she has worked in a variety of clinical settings including: upper extremity, chronic pain, neurological, work & industry, and pediatrics. Currently, Alyssa is the Clinical Education Coordinator and an assistant professor at Pacific University.

Dr. Jennifer Taylor-Cousar is an amazing woman I can't wait to meet in person one day.  She is a Board Certified Pediatric and adult pulmonologist at National Jewish Health in Colorado. She's a rock star in the world of CF, and she's doing incredible work raising awareness about systemic and individual bias and racism in medicine. She also talks about the importance of representation in the field of medicine. I hope after you hear this podcast you are more inspired to speak up and do more to change the world.About Dr. Taylor-Cousar:Dr. Taylor-Cousar is a tenured professor of adult and pediatric pulmonary medicine at NationalJewish Health (NJHhttps://www.nationaljewish.org/home), where she serves as the Medical Director of Clinical Research Services,President of the Medical Staff, and is co-director of the Adult Cystic Fibrosis (CF) Program andDirector of the CF Therapeutics Development Network (TDN) center. She received herundergraduate degree in human biology from Stanford University, and completed her doctoratein medicine, combined residency in internal medicine and pediatrics, and her combinedfellowship in adult and pediatric pulmonary medicine at Duke University. She obtained herMaster of Clinical Science from the University of Colorado.Dr. Taylor-Cousar's expertise is clinical trial design and conduct; she has been national/globalprimary investigator on multiple CF TDN trials. Her investigator-initiated research focuses onthe development and evaluation of novel therapies for the treatment of CF, and on sexual andreproductive health in people with CF. Additionally, she serves on a number of nationalscientific advisory committees for the Cystic Fibrosis Foundation, American Thoracic Societyand the National Institutes of Health. She is an Associate Editor for the Journal of Cystic Fibrosisand a member of the International Advisory Board for the Lancet Respiratory Medicine.Dr. Taylor-Cousar is an elected member of the American Society for Clinical Investigation(ASCI). Her recent awards include the American Thoracic Society's Distinguished AchievementAward (2023,) the American Thoracic Society William J. Martin II Public Advisory RoundTable Distinguished Achievement Award (2022), the Emily's Entourage CF Trailblazer Award(2022) and the Cystic Fibrosis Research Incorporated CF Champion Award (2021).Michele and Terry Wright screening tool: https://noaacf.org/the-wright-cystic-fibrosis-screening-tool/Please consider making a donation: https://thebonnellfoundation.org/donate/The Bonnell Foundation website: https://thebonnellfoundation.orgBonnell Foundation email: thebonnellfoundation@gmail.comThanks to our sponsors:Vertex:  https://www.vrtx.comGenentech: https://www.gene.comViatris: https://www.viatris.com/en

Host: Jeffrey Freiberg, MD, PhD The field of infectious diseases is always evolving thanks to new research studies, data, and treatment options. To help us catch up on some of these essential updates, Dr. Jeffrey Freiberg is here to give us an overview of the “What's Hot in ID in Clinical Science” session he helped develop for IDWeek 2023.

A conversation with Dr. J.P. Barfield, Department Chair of Applied Physiology, Health, & Clinical Sciences at the University of North Carolina at Charlotte about his team's study published in the September 2023 issue of CJSM about concussion testing in wheelchair athletes. We're also joined by Mack Johnson, formed D1 collegiate wheelchair basketball player to discuss the care of wheelchair sport athletes.

Dr. Brady is also one of the foremost authorities on properly diagnosing and treating fibromyalgia, he has been featured in top popular media including Dr. Oz, ELLE and NPR. His latest Amazon best-selling book, The Fibro-Fix, was published by Rodale and released in July of 2016. In today's episode we discuss the complex topic of metabolomics, genomics and all the other omics. Dr. Brady will explain how this information can provide a way to analyze someone's unique physiology and personalize their care. What You Will Learn: 1. How Dr. Brady's passion for finding the answers to his mom's cancer diagnosis led him down non-conventional approaches. Today, Dr. Brady is an international expert in some of the hardest to treat chronic diseases, including fibromyalgia and Myalgia encephalomyelitis/Chronic fatigue syndrome (ME/CFS). 2. The power of the therapeutic relationship and the importance of a physician to be open- minded and seek solutions for their patient. 3. What “omics” medicine is and how it personalizes and tailors medicine. Dr. Brady reviews how it differs from diagnosing pathologies from traditional labs. 4. The difference between analyzing a gene variation, a SNP (single nucleotide polymorphism), such as MTHFR, in genomics and using metabolomics. 5. What is hypervigilance and how metabolomics can determine which are the best supplements to take based on various stress markers. 6. How essential oils can impact metabolomics and hypervigilance. 7. How essential oils are underutilized and understudied in functional and integrative medicine and why we should use them more for the full healing power they have. 8. The importance of “omic” testing and why one may want to consider it over just treating symptoms. 9. How to look for a reputable lab and why split sampling isn't the best way to assess the accuracy of a lab. 10. The Fibro-Fix book. 11. Dr. Brady's favorite oils (citrus) and how they uplift mood and can help with focus. 12. Closing Questions: What Dr. Brady does daily for self-care and what he thinks we should ditch and replace with instead. Bio of Dr. David M. Brady, ND, DC, CCN, DACBN, IFMCP, FACN Dr. David M. Brady has over 30-years of experience as an integrative medicine practitioner and 25 years in health sciences academia. He is a licensed naturopathic medical physician in Connecticut and Vermont, is board certified in functional medicine and clinical nutrition, and a fellow of the American College of Nutrition. Dr. Brady is the Chief Medical Officer for Diagnostic Solutions Labs, LLC and Designs for Health, Inc. He is currently in private practice in the integrative medicine group Whole Body Medicine, in Fairfield, CT (USA). Dr. Brady is the former long-term vice president of the Division of Health Sciences and director of the Human Nutrition Institute at the University of Bridgeport in Connecticut, where he continues to serve as director and professor emeritus of nutrition. He has appeared on the plenary speaking panel of some of the largest and most prestigious conferences in the field including IFM, ACAM, A4M, ACN, IHS, AANP, AIHM and many more. Dr. Brady has published a multitude of peer-reviewed scientific papers and textbooks related to functional and naturopathic medicine, clinical nutrition, chronic pain, autoimmunity, and functional gastroenterology. Links to learn more about Dr. Brady, his companies, and offerings: Dr. David M. Brady  Chief Medical Officer, Designs for Health, Inc. & Diagnostic Solutions Lab, LLC Director Emeritus, Nutrition Institute & Associate Professor of Clinical Sciences, University of Bridgeport Private Clinical Practice, Whole Body Medicine (Fairfield, CT-USA) Author of The Fibro-Fix Dr. Brady on Facebook Designs for Health Video Dr. Brady's Presentation: Anxiety, Depression, and Stress: A Multi-Omics Approach Dr. Brady's Articles and Publications Learn more about your ad choices. Visit megaphone.fm/adchoices

When it comes to the next pandemic, the question is not "if" but "when". In this compelling episode, you will meet the most likely candidates for the next outbreak, and find out how well-prepared we are for it.For more information on Transmission, go to www.itg.be/podcast.This episode features:Kevin Ariën, virologist, Head of Department of Biomedical Sciences, ITM AntwerpLaurens Liesenborghs, infectious disease specialist, Head of the Unit of Clinical Emerging Infectious Diseases, ITM AntwerpKatharina (Kathy) Kreppel, epidemiologist, Head of the Unit of Emerging Infectious Diseases, ITM AntwerpJohan van Griensven, neglected tropical diseases expert, Head of Department of Clinical Sciences , ITM AntwerpIsabel Brosius, infectious disease specialist, Unit of Tropical Diseases, ITM AntwerpAlexandre Delamou, medical doctor and public health expert, Director of Centre d'Excellence d'Afrique, GuineaJean-Jacques Muyembe, virologist and microbiologist, Director of the National Institute of Biomedical Research (INRB), DRCFollow ITM and our work on:FacebookInstagramTwitterLinkedInTo learn more about outbreaks and outbreak research,  go to www.itg.be/outbreaks.Strategy & Creation: OnlyhumansCreation & Production: Sonhouse 

Meet the members of the Outbreak Research Team. Follow in the footsteps of the most talented scientists as they travel the world to get a grasp on global health challenges, or toil away in hi-tech labs to solve the complex riddles that come with new infectious diseases. (c) The news broadcasts at the beginning of this episode were taken from VRT-Beeldarchief. The audio interview with Isabel Brosius was broadcast in "Laat" on 19 May 2022.For more information on Transmission, go to www.itg.be/podcast.This episode features:Laurens Liesenborghs, infectious disease specialist, Head of the Unit of Clinical Emerging Infectious Diseases, ITM AntwerpKatharina (Kathy) Kreppel, epidemiologist, Head of the Unit of Emerging Infectious Diseases, ITM AntwerpJohan van Griensven, neglected tropical diseases expert, Head of Department of Clinical Sciences , ITM AntwerpCharlotte Gryseels, medical anthropologist, senior researcher in Unit of Socio-Ecological Health Research, ITM AntwerpIsabel Brosius, infectious disease specialist, Unit of Tropical Diseases, ITM AntwerpJean-Jacques Muyembe, virologist and microbiologist, Director of the National Institute of Biomedical Research (INRB), DRCAlexandre Delamou, medical doctor and public health expert, Director of Centre d'Excellence d'Afrique, GuineaFollow ITM and our work on:FacebookInstagramTwitterLinkedInTo learn more about outbreaks and outbreak research,  go to www.itg.be/outbreaks.Strategy & Creation: OnlyhumansCreation & Production: Sonhouse 

Stuart McErlain-Naylor and Franco Impellizzeri (Sports Coach in Clinical Science and Professor of Sports, Exercise and Science in Medicine at the University of Technology Sydney) talk about the training load training load monitoring in elite sports, the limitations of this as well as the lessons that can be taken from medicine to assist the development of knowledge in this area.Timestamps:00:00 - 04:23 - Introductions and career background of our guest 04:24 - 14:10 - What is training load?14:11 - 19:47 - How is this currently being applied in elite sports settings?19:48 - 25:42 - Will coaches use this in real time to advance training sessions?25:43 - 29:11 - What are the current limitations with how load limitations are being used now?29:12 - 34:50 - What should future studies do differently? 34:51 - 42:25 - How would this research be done in other fields and what can be learnt from that?42:26 - 45:15- How can we improve the dialogue between academic and practise of sport science?45:16 - 53:00 - Where do you see train load monitoring in the next 5 years?53:01 - 53:44 - Outro

Pamela Toto, a professor at the University of Pittsburgh Department of Occupational Therapy, shares details on the Pitt Healthy Home Laboratory which develops and evaluates technologies and home services to help people live safely and independently at home. About Pam Pamela Toto, PhD, OTR/L, BCG, FAOTA, FGSA, is a Professor at the University of Pittsburgh and senior scientist in the School of Health and Rehabilitation Sciences Healthy Home Laboratory. She is also a Doctor of Clinical Science in Occupational Therapy Program at the University of Pittsburgh, an online post-professional clinical doctorate focused on strategies to implement best evidence in clinical practice. She is an occupational therapist, researcher and educator who is internationally recognized within her field for her expertise in gerontology. Board Certified in Gerontology and a Fellow of  the American Occupational Therapy Association and a Fellow of the Gerontological Society of America, Dr. Toto has over 30 years of clinical experience as an occupational therapist providing services for older adults in the community and in long term care settings. Dr. Toto's clinical and research interests focus on the implementation of client-centered interventions in “real world” settings to promote independence, participation and healthy aging in older adults.  She is a national trainer and instructor for evidence-based programs including CarFit, Matter of Balance, and Skills2Care, and  has over 100 peer-reviewed publications and presentations, combined, on topics related to successful aging. Key Takeaways Healthy Home lab brings together professionals who help people age in place to educate students about challenges and develops solutions. Professionals include nurses, social workers, engineers, occupational and physical therapists, physicians, and physician assistants. Occupational therapists are trained to help people across the lifespan with activities of daily living and help people maximize their bodies and minds. The goal is helping older adults remain autonomous and independent as long as possible.  Housing stock in the United States is not ready for aging in place. Only 10% of homes are ready for people to age in place, and in the Northeast it is 6.8%. The dynamic between older adults and adult children is challenging. Older adults want autonomy and adult children choose safety over independence. Older adults are willing to accept some risk to maintain their dignity. It is important to have hard discussions when people are well rather than waiting for a crisis. We must figure out better ways to minimize the risk and find solutions for older adults. Eliminating a person's chosen activity is not the solution. Young people have fewer natural opportunities to interact with older adults, so working with older adults is not their first impetus. Occupational therapy students are excited about the shift to a preventative model versus Medicare reimbursed “damage control.”

GET MY FREE INSTANT POT COOKBOOK: https://www.chefaj.com/instant-pot-download ------------------------------------------------------------------------------------ MY LATEST BESTSELLING BOOK: https://www.amazon.com/dp/1570674086?tag=onamzchefajsh-20&linkCode=ssc&creativeASIN=1570674086&asc_item-id=amzn1.ideas.1GNPDCAG4A86S ----------------------------------------------------------------------------------- Disclaimer: This podcast does not provide medical advice. The content of this podcast is provided for informational or educational purposes only. It is not intended to be a substitute for informed medical advice or care. You should not use this information to diagnose or treat any health issue without consulting your doctor. Always seek medical advice before making any lifestyle changes. to see Dr Gearhardt's talk on The Science of Food Addiction: https://www.youtube.com/watch?v=yJ1EhYrYpDQ&t=11s Dr. Ashley Gearhardt is a Professor of Psychology in the Clinical Science area at the University of Michigan. She received her Ph.D. in clinical psychology at Yale University with training on the underpinnings of both excess food and alcohol consumption. Dr. Gearhardt currently investigates the contribution of reward dysfunction (e.g., craving, liking) to eating-related problems across the lifespan. She uses a multi-method approach to explore the neurobiological, psychological, and behavioral factors that contribute to problematic eating behavior. Dr. Gearhardt also investigates the role of addictive processes in compulsive overeating and is the Director of the Food Addiction Science and Treatment Laboratory. She created the Yale Food Addiction Scale, which has been cited over 1000 times and has been translated into over 10 languages. Her research has received funding from the National Institute of Health and the American Heart Association. She has published over 150 peer-reviewed articles and her research has been featured on media outlets including the New York Times, ABC News, the Today Show, and Time Magazine. Website: https://sites.lsa.umich.edu/fastlab/

The current nursing shortage is expected to worsen as the baby boomer generation continue to near retirement and many nurses retire while simultaneously our population will require more care due to age, leaving hospitals how to figure out how to do more with less.  Clinical Science is a patient workload solution that uses data from the EMR to ensure staff are deployed in the most effective manner possible to provide the care required and helps leaders make fair, safe, and equitable patient assignments.

Dr. Douglas L. Beck is a well-known figure in audiology and the Vice President of Clinical Sciences for Cognivue, a company that manufactures adaptive hearing solutions for the modern age. Dr. Beck is a prolific author on the subject, having 185 different publications to date through Oticon, where he worked as Vice President of Academic Sciences from 2005-22. He also serves as an Adjunct Professor at State University of New York at Buffalo and the Senior Editor of Clinical Research at Hearing Review. In this episode… With modern medicine and science, research is rapidly accelerating. Particularly for burgeoning or underexplored fields, the pace of research can make it difficult for the public to catch up — making it even more important for experts to inform everyday people on the key takeaways from recent studies. Dr. Douglas Beck is an established figure in audiological research. His current role at Cognivue sits at the intersection between cognition and hearing loss. The overlap between the two has only grown with further research, and now, you can learn even more about the connection. In this episode of the ListenUp! Podcast, Dr. Mark Syms talks once again with Dr. Douglas Beck, the Vice President of Clinical Sciences at Cognivue, to explore the cutting edge research on hearing loss and cognitive decline. They discuss some of the new studies, the history of the research, and the risk factors for dementia. The two also go through Cognivue's test and how it works.

Getting a mental health diagnosis is a powerful thing. It can make you feel less alone, but it can also impact or alter your sense of identity. In this episode of Hold On, a live national call-in about our mental health, Anna talks to Dr. Craig Rodriguez-Seijas, Assistant Professor of Psychology in Clinical Science at the University of Michigan, about his work studying bias in mental health diagnostics, particularly among LGBTQ+ individuals, and takes listener calls about how a diagnosis has shaped their sense of identity, for better or worse. Plus, Aneri Pattani, Senior Correspondent at Kaiser Health News, explains what investments the Biden administration is making toward mental health, and how soon we might see progress.

Nathalie completed a Bachelor of Clinical Science in 1999 followed by a Master of Health Science 2001 at Victoria University. Over the past 20 years, Nathalie has worked alongside some notable Osteopaths along the eastern side of Australia - from Launceston to the Gold Coast and Sydney before settling back home in Melbourne in 2012. From a sporting background, Nathalie has enjoyed providing Osteopathic care to local sports teams. Nathalie's Osteopathic interests have evolved down the path of the Biodynamics of Osteopathy. Under the guidance of its founder, Dr James Jealous, and several other osteopathic teachers, Nathalie uses these principles into her Osteopathic treatment. She is also part of a national study group and teaching collective that shares osteopathic wisdom to students and osteopaths alike.

On today's episode: special education professor and researcher Rhonda NeseNese is an assistant professor in the Department of Special Education and Clinical Sciences at the University of Oregon College of Education. Her research focuses on reducing exclusionary school disciplinary practices. She also provides technical assistance to state, district and school level teams across the nation.Topics 02:08 Implicit bias explained 05:06 Unpacking the school-to-prison pipeline 08:08 Helping teachers understand the “why” behind behavior 11:45 Alternatives to suspension 14:56 Helping students re-adjust to the classroom post-Covid 17:00 How parents can advocateFor more information on Nese's work, you can visit her website neselab.org or follow her on Twitter at @nese_lab.

Dr. Bill Stoops provides an overview of the pharmacology, effects, and prevalence of cocaine, in addition to treatments for cocaine use disorder. Dr. Bill Stoops is an Associate Director for Clinical Science in the Substance Use Priority Research Area, and a Professor in the Departments of Behavioral Science, Psychiatry, and Psychology, and in the Center for Drug and Alcohol Research, at the University of Kentucky.

Can some foods be addictive? What's happening in our bodies when we consume ultra processed foods with addictive properties? And how can we be more conscious and aware about the impact of food addiction on our bodies and lives? Ashley Gearhardt, Associate Professor of Psychology in the Clinical Science area at the University of Michigan. She also earned her B.A. in psychology from The University of Michigan as an undergraduate. While working on her doctorate in clinical psychology at Yale University, Dr. Gearhardt became interested in the possibility that certain foods may be capable of triggering an addictive process. To explore this further, she developed the Yale Food Addiction Scale (YFAS) to operationalize addictive eating behaviors, which has been linked with more frequent binge eating episodes, an increased prevalence of obesity and patterns of neural activation implicated in other addictive behaviors. Looking for more in-depth learning experiences on Anatomy & Physiology or other topics? Sign up for Pearson+ today to explore content from experts like Joan Salge Blake. Learn more about your ad choices. Visit podcastchoices.com/adchoices

SPP 160: ADHD Supports in the Schools #psychedpodcast is excited to speak with Dr. Fabiano on ADHD! https://case.fiu.edu/about/directory/profiles/fabiano-gregory.html Dr. Fabiano is a professor of psychology at Florida International University (FIU). He is a core faculty member in the Clinical Science in Child in Adolescent Psychology Doctoral Program and the Center for Children and Families (CCF).… Continue reading SPP 160: ADHD Supports in the Schools

In this episode, I am joined by Emma Jack, physiotherapist and coach, to discuss her journey from burnout to breakthrough. Emma was overwhelmed and unsatisfied with her career path until a panic attack in 2016 led her to reflect and make a change. Emma decided to take a step back and focus on herself to build a more sustainable, fulfilling career. This is her story and her advice for other healthcare practitioners.   Show notes:    00:05:17 Check in with yourself. 00:12:17 Fill yourself up first, serve others. 00:17:05 Take time for yourself. 00:26:28 Our worth is not outcomes. 00:30:49 Take care of yourself. 00:40:22 Lean into your true self. 00:40:40 Stay curious and evolve.   More About Emma:   Emma is a sport and orthopedic physiotherapist and owns her own practice Press Play  Physiotherapy and Pilates in London, Ontario, Canada. She holds a Masters of Physiotherapy as well  as a Masters of Clinical Science, has her Sport Physiotherapy Diploma, is a Fellow of the Academy of  Manual and Manipulative Physical Therapy and is a lead therapist with the Canadian National  Women's Hockey Team.  Sounds pretty cool, right? While those accomplishments and credentials do bring a sense of pride,  Emma also recognizes that many of those things are ultimately what left her feeling intense anxiety,  chronic stress, overwhelm and burnt out. Her credentials may span two lines on a business card, but  in recent years Emma has totally transformed her practice and life in order to ensure that her  accomplishments no longer define her. Now, much of her time is spent working as a Co-Active  coach helping other clinicians show up fully for their lives and careers in a way that feels authentic,  sustainable and most importantly, fun!   Resources from this Episode:    Emma's Resources Website Instagram Twitter   Subscribe to Healthy, Wealthy & Smart: Website:                      https://podcast.healthywealthysmart.com Apple Podcasts:          https://podcasts.apple.com/us/podcast/healthy-wealthy-smart/id532717264 Spotify:                        https://open.spotify.com/show/6ELmKwE4mSZXBB8TiQvp73 SoundCloud:               https://soundcloud.com/healthywealthysmart Stitcher:                       https://www.stitcher.com/show/healthy-wealthy-smart iHeart Radio:               https://www.iheart.com/podcast/263-healthy-wealthy-smart-27628927  

Hosts Gregg Masters and Fred Goldstein meet Thomas E. Dobbs, MD, Dean of the John D. Bower School of Population Health, at the University of Mississippi Medical Center, and Melissa R. Stephens, MD, Associate Dean of GME and Population Health and Professor of Clinical Sciences at the William Carey University College of Osteopathic Medicine. They discuss the intersection of public health, population health and the retooling of the acute care health system to remedy the many disparities in evidence in the United States. In addition to his role as Dean, Dr. Dobbs serves as the executive director of the Myrlie Evers-Williams Institute for the Elimination of Health Disparities. He has a clinical position within the Division of Infectious Disease, working specifically in the fields of HIV and sexually transmitted infections with a focus on the intersection of disease and the social determinants of health. Dr. Dobbs has a long career working at the crossroads of clinical medicine and public health as a physician, researcher and public health leader. He has held numerous leadership roles within the Mississippi State Department of Health including State Epidemiologist and State Health Officer (a role through which he directed the state's response to the COVID pandemic). In his role as State Health Officer, Dr. Dobbs focused the agency on addressing the numerous health inequities that plague the state. Additionally, he has worked in leadership roles nationally and internationally in the fight against diseases such as HIV and tuberculosis.

Dr. Lizette Warner is the CEO of Optimum Vobis.  She is a TedX speaker and the author of Power, Poise, and Presence: A New Approach to Authentic Leadership .  Lizette was previously a Senior Director of Clinical Science at Philips, focusing on MR Therapy (meditation relaxation), and she holds a PHD in Philosophy from the Mayo Clinic School of Medicine.  We discuss her approach to authentic leadership an how to harness the power of biomarkers to defeat doubt and fear.  

This episode features Dr. Angela Mund, Chair for the Department of Clinical Sciences at the Medical University of South Carolina & President of the American Association of Nurse Anesthesiology. Here, she discusses challenges surrounding workforce shortages & access to care, the future of nurse anesthesia education, different ways to manage healthcare costs, and more.

https://cutt.ly/WhatAreYourThoughts (https://cutt.ly/WhatAreYourThoughts) Advocacy can take many forms, from speaking out publicly to organizing groups to writing letters to elected officials. Whatever the form, advocacy is an important way to bring attention to issues and make change. And although anyone can be an advocate, there's definitely an art to being an “Effective Advocate”. Today, Dr. Gaggino talks with Dr. Pam Shaw who has perfected the art of advocacy. Among the many hats that Dr. Pam Shaw wears, (i.e., Professor of Pediatrics, Assistant Dean for Clinical Sciences, Associate Vice Chancellor for Student Services, President of the Kansas Chapter of the AAP– just to name a few), her passion to make things better for all children has no boundaries.  Listen in to not only Dr. Shaw's personal journey, but also about her work in Washington, D.C. on behalf of all children everywhere.    [00:33 -12:46] Opening Segment Dr. Gaggino introduces us to Dr. Pam Shaw What drives Dr. Shaw's passion to be an AAP Advocate on the national level?   What does an AAP Advocate actually do? For children's issues, you need lots of organizations working together [12:47- 25:03]  Bipartisan Concerns   Good opportunity to start with AAP Politics are affecting the doctor/patient relationship Learning opportunities are created when local chapters share successes as well failures with each other In order to make an impact, VOTE!! [25:04 -41:20]  Emphasis On Pediatrician's Needs Safety Training Vaccine Funding Mental Health parity Payment for Services Coding review     [41:21 -45:13] How Can Pediatricians Up Their Game? Join your local chapter of AAP Sign up to be a key contact for AAP VOTE! (And encourage family and friends to vote as well) [45:14 - 50:40]  Closing segment Takeaway You can reach Dr. Pam ShawFacebook: https://www.facebook.com/pam.shaw.108/about (Pam Shaw | Facebook) Instagram:  https://www.instagram.com/pkshaw/ (@pkshaw) Twitter: https://twitter.com/Pkshaw1 (@Pkshaw1) Links to resources mentioned on the show   HRSA (Health Resources and Services Administration) https://www.hrsa.gov/grants/apply-for-a-grant (Apply for a Grant | HRSA)   COSGA (Committee for State Government Affairs) https://www.aap.org/en/community/aap-committees/committee-on-state-government-affairs/ (Committee on State Government Affairs (COSGA) (aap.org))   American Association of Pediatrics https://www.aap.org/ (https://www.aap.org/) “67​,000 pediatricians committed to the optimal physical, mental, and social health and well-being for all infants, children, adolescents, and young adults”   Get a non-partisan Vote-ER badge and sign-up families to vote -  https://vot-er.org/ana/ (https://vot-er.org/ana/) Get your FREE QR badge https://vot-er.org/badge/ (https://vot-er.org/badge/)   AAP Advocacy email  stgov@aap.org aap.org/stateadvocacy Federal Advocacy email  kids1st@aap.org aap.org/en/advocacy AAP Media Relations email  aap.org/en/news-room/general-media-mailboxaap.org/en/news-room Other episodes you may like: Episode #66  School Shootings: The Aftermath and Prevention  https://cutt.ly/SchoolShootings (https://cutt.ly/SchoolShootings) Key quotes for Twitter: “ I can take care of their health, but if they're actually going to thrive, I have to advocate for them to be involved in programs that I know work...Pam Shaw "In the DNA of a pediatrician….. Is advocacy"..  Pam Shaw THANK YOU FOR YOUR SUPPORT! Pediatric Meltdown was listed as https://blog.feedspot.com/pediatric_podcasts/ (a Top 20 Pediatric Podcast on FeedSpot). If you'd like to connect with me, you can find me on https://www.linkedin.com/in/dr-lia-gaggino-80322a31/ (LinkedIn), https://www.facebook.com/DrLiaGaggino/ (Facebook), http://instagram.com/pediatricmeltdown...